Immature Granulocyte Relative
IG REL
Description
"Immature Granulocyte Relative" test calculates the percentage of immature granulocytes compared to total white blood cells, offering insight into how your immune system is reacting to stress or illness. It’s commonly used in cases of suspected infection, inflammation, or bone marrow disorders. High values may reflect active immune response, while low levels are usually normal. Doctors use this test alongside other results to guide diagnosis and care. Regular tracking supports effective treatment and helps monitor immune system recovery.
Category
Blood Cells
Procedure
Invasive
Sample Type
Blood – Whole Blood
Units
Percentage
Procedure Category
Blood Draw
Test Group
Hematology Group, Blood Count Differentials Group
Test Group Description
Blood Count Differentials Group: This group comprises tests essential for evaluating the different types of blood cells, offering detailed insights into blood cell composition, and aiding in the diagnosis of various blood disorders. Hematology Group: Tests within this group focus on evaluating various aspects of blood health and function. These assessments provide insights into red blood cells, white blood cells, platelets, and other components of the blood.
Optimal Range
For All Individuals:
Conventional Unit: 0.00–0.50%
SI Unit: Not Applicable
Normal Range
For All Individuals:
Conventional Unit: 0.00–0.50%
SI Unit: Not Applicable
Results That Differ From The Norm (Direct and Indirect Causes)
Increased levels may indicate:
Chronic myelogenous leukemia (Cancer of the blood cells)
Inflammation
Polycythemia vera (Bone marrow disorder leading to overproduction of blood cells)
Primary myelofibrosis (Bone marrow disorder causing fibrosis and impaired blood cell production)
Primary thrombocythemia (Overproduction of platelets)
- ...
Key Reasons For Testing
Infection Monitoring: Evaluates bacterial infections and immune responses.
Sepsis Indication: Assists in detecting systemic inflammation or sepsis early.
Bone Marrow Function: Reflects marrow response to infection or hematologic issues.
Prognostic Tool: Correlates relative counts with severity and outcomes in critical illness.
Therapy Response: Tracks antimicrobial effectiveness and infection resolution.
Leukemia Diagnosis: Differentiates between reactive and neoplastic granulocyte disorders.
Stress Response: Highlights physiological changes due to trauma or surgery.
Health Status Conditions It May Be Used To Assess
Currently, this test is not directly associated with any conditions listed on the Health Status page. However, it may be included as part of a broader set of tests linked to specific health conditions.
Some Prominent Medical Labs That May Offer This Test
Please note that this particular test has not been associated with any of the listed prominent medical labs. We recommend enquiring with your private physician or nearest hospital to determine where this specific test can be performed.
References
Important Note
Any medical procedure yielding results outside the norm may be directly or indirectly linked to the conditions outlined on this page. Various factors, including genetics, medication and supplement usage, recent illnesses, pregnancy, pre-test eating, smoking, and stress, can impact the test's outcome. Additionally, factors like false positives, false negatives, inaccurate analyses, and others can influence results.
Reference ranges, which help healthcare professionals interpret medical tests, may vary depending on age, gender, and other factors. They may also differ between laboratories due to variations in instruments and methods used. Optimal ranges are designed for preventive purposes, aiming to identify trends and potential risks early, while normal ranges reflect conventional laboratory values indicating no current disease or pathology. Your healthcare practitioner may have specific reasons for testing that deviate from the usual or may interpret results differently based on individual circumstances. Proper interpretation typically involves considering clinical findings and other diagnostic tests. Hence, it is crucial to provide your healthcare professionals with a comprehensive medical history, consult with them for result interpretation, and follow their guidance for potential re-testing or additional diagnostics.
Disclaimer
This content is provided solely for informative and educational purposes. It is not intended as a substitute for medical advice or treatment from a personal physician. Regarding the interpretation of their medical test results and/or specific health questions, it is recommended that all readers and viewers consult their physicians or other qualified health professionals. The publisher is not responsible for any adverse health effects that may result from reading or following the information in this educational content. Before beginning any nutrition, supplement, or lifestyle program, all viewers, especially those taking prescription or over-the-counter medications, should consult their physician or health care practitioner.
Please note that while prominent lab names are included in this content, we cannot guarantee that these labs offer all the tests mentioned. For confirmation, individuals should contact the labs directly or consult their medical practitioners. The information provided reflects general knowledge at the time of publication and may not include recent updates or emerging research. Readers should verify details with qualified professionals to ensure the most up-to-date and accurate guidance.
[1] Kratz A, Maloum K, O’Malley C, et al. The automated measurement of immature granulocytes: performance characteristics and utility in predicting infection and sepsis in the adult population. Am J Clin Pathol. 2006;125(5):763-769.
[2] Crouser ED, Parrillo JE, Seymour C, et al. Improved early detection of sepsis in the ED with a novel monocyte distribution width biomarker. Chest. 2017;152(3):518-526.
[3] Ozdemir ZC, Yildiz I, Yilmaz D, et al. Immature granulocyte percentage in the prediction of bacteremia and sepsis in children. Clin Lab. 2019;65(1).
[4] Seok Y, Choi JR, Kim J, et al. Delta neutrophil index: a promising marker for the diagnosis of bacterial infections. Clin Chem Lab Med. 2012;50(8):1439-1442.
[5] Üstün Y, Engin A, Arikan S, et al. Predictive value of immature granulocyte percentage in the diagnosis of acute appendicitis. Clin Lab. 2018;64(5):745-751.
[6] Abidi K, Khoudri I, Belayachi J, et al. Eosinopenia, an early marker of increased mortality in critically ill medical patients. Intensive Care Med. 2011;37(7):1136-1142.
[7] Karon BS, Tolan NV, Wockenfus AM, et al. The role of the relative immature granulocyte count as a marker of infection or sepsis in an adult critical care population. Clin Biochem. 2009;42(10-11):1074-1077.
[8] Sun Q, Yang F, Xu Z, et al. Diagnostic value of immature granulocyte percentage in patients with fever. Clin Chem Lab Med. 2019;57(5):786-791.
[9] van der Geest PJ, Mohseni M, Peters EJ, et al. The association of immature granulocytes with disease severity in the emergency department. Crit Care Res Pract. 2018;2018:1984193.
[10] Velasco C, Ramirez-Peredo J, Berenguer M, et al. Clinical utility of immature granulocyte count in sepsis. Lab Hematol. 2015;21(3):164-168.
[11] Maner SK, Moideen N, George O, et al. The predictive value of relative immature granulocyte count in patients with systemic inflammatory response syndrome. Eur J Clin Invest. 2018;48(2).